Institutional Ownership Seres Therapeutics, Inc. (MCRB)
This table provides information about the institutional ownership of Seres Therapeutics, Inc. (MCRB). We have compiled data on the 93 institutions that hold shares in the stock, with a total of 46.7 Million shares, which have been reported (via 13F filing form) to have a value of $38.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Flagship Pioneering Inc.
Cambridge, MA |
Aug 14, 2024 Q2 2024 |
23,117,045
shares
|
$19 Million
1.99% of portfolio
|
Q3 2022
Added 60.77%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
6,285,749
shares
|
$5.15 Million
0.0% of portfolio
|
Q2 2024
Reduced 6.67%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2024 Q2 2024 |
2,407,112
shares
|
$1.97 Million
0.21% of portfolio
|
Q2 2024
Added 165.36%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
1,777,601
shares
|
$1.46 Million
0.0% of portfolio
|
Q2 2024
Added 72.99%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,762,157
shares
|
$1.44 Million
0.0% of portfolio
|
Q2 2024
Reduced 74.18%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 15, 2024 Q2 2024 |
1,427,700
shares
|
$1.17 Million
0.0% of portfolio
|
Q2 2024
Added 124.98%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
1,133,625
shares
|
$929,572
0.0% of portfolio
|
Q2 2024
Reduced 46.84%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
1,004,978
shares
|
$824,081
0.0% of portfolio
|
Q2 2024
Reduced 81.48%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
721,758
shares
|
$591,841
0.0% of portfolio
|
Q2 2024
Reduced 8.02%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
707,073
shares
|
$579,799
0.0% of portfolio
|
Q2 2024
Added 718.01%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 13, 2024 Q2 2024 |
666,951
shares
|
$546,899
0.0% of portfolio
|
Q2 2024
Reduced 37.32%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2024 Q2 2024 |
525,947
shares
|
$431,276
0.0% of portfolio
|
Q2 2024
Reduced 29.62%
|
|
|
Eversept Partners, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
418,208
shares
|
$342,930
0.02% of portfolio
|
Q2 2024
Reduced 69.89%
|
|
|
Vontobel Holding Ltd.
|
Oct 15, 2024 Q3 2024 |
394,826
shares
|
$323,757
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Lion Point Capital, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
340,761
shares
|
$279,424
0.52% of portfolio
|
Q4 2023
Reduced 50.74%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
339,548
shares
|
$278,429
0.0% of portfolio
|
Q2 2024
Reduced 82.55%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
314,177
shares
|
$257,625
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Pennant Investors, LP
Summit, NJ |
Aug 14, 2024 Q2 2024 |
292,300
shares
|
$239,686
0.06% of portfolio
|
Q4 2023
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2024 Q2 2024 |
267,398
shares
|
$219,266
0.0% of portfolio
|
Q2 2024
Reduced 10.3%
|
|
|
Ubs Group Ag
|
Aug 13, 2024 Q2 2024 |
200,726
shares
|
$164,595
0.0% of portfolio
|
Q2 2024
Added 89.42%
|
|
|
Centiva Capital, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
187,800
shares
|
$153,996
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Oct 17, 2024 Q2 2024 |
171,086
shares
|
$140,290
0.0% of portfolio
|
Q2 2024
Reduced 64.18%
|
|
|
Lpl Financial LLC
Fort Mill, SC |
Aug 07, 2024 Q2 2024 |
140,625
shares
|
$115,312
0.0% of portfolio
|
Q2 2024
Added 8.36%
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Aug 14, 2024 Q2 2024 |
127,634
shares
|
$104,659
0.02% of portfolio
|
Q2 2024
New holding
|
|
|
Y Intercept (Hong Kong) LTD
|
Aug 14, 2024 Q2 2024 |
123,590
shares
|
$101,343
0.0% of portfolio
|
Q2 2024
New holding
|